Clinical trial
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
NCT02281474
Study timeline
Study start (unknown)2014-11-01Date precision: month
Registry last updated2015-12-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson's Diseaseunresolved
Parkinson's Disease Dementiaunresolved
Diffuse Lewy Body Diseaseunresolved
Interventions
NilotinibDRUG · verified · RxNorm: nilotinib
Sponsors & collaborators
Georgetown Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02281474 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.